Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?

Eve Bédouelle, Jean Michel Nguyen, Emilie Varey, Amir Khammari, Brigitte Dreno

Open source

DOI: 10.1159/000518718
Published: 2021-10-27
Container: Dermatology
Publisher: S. Karger AG
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1159/000518718,
  title = {Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?},
  author = {Eve Bédouelle and Jean Michel Nguyen and Emilie Varey and Amir Khammari and Brigitte Dreno},
  year = {2021},
  journal = {Dermatology},
  doi = {10.1159/000518718},
  url = {https://doi.org/10.1159/000518718}
}

RIS

TY  - JOUR
TI  - Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?
AU  - Eve Bédouelle
AU  - Jean Michel Nguyen
AU  - Emilie Varey
AU  - Amir Khammari
AU  - Brigitte Dreno
PY  - 2021
JO  - Dermatology
DO  - 10.1159/000518718
UR  - https://doi.org/10.1159/000518718
ER  -

APA

Bédouelle, E., Nguyen, J. M., Varey, E., Khammari, A., & Dreno, B. (2021). Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?. Dermatology. https://doi.org/10.1159/000518718

Source records

crossref · retrieved 2026-11-06T13:41:50.402Z